Loading...
You are here:  Home  >  Health  >  Current News

Roche’s Tecentriq wins FDA approval for treating advanced bladder cancer



(Reuters) - Genentech, a unit of Swiss drugmaker Roche Holding AG, said on Monday it got approval from the U.S. Food and Drug Administration for its already approved immunotherapy drug, Tecentriq, to treat advanced bladder cancer.


Other News

VP Biden to report on Cancer Moonshot progress WASHINGTON (Reuters) - U.S. Vice President Joseph Biden will release on Monday a report on the administration's Cancer Moonshot initiative designed ...
Sanofi files U.S. antitrust lawsuit against Mylan over EpiPen (Reuters) - Sanofi SA on Monday sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiP...

Found news:

Loading...

You might also like...

Novartis receives EU approval for breast cancer drug Kisqali

Read More →